원료 사전 탐색/citric-acid/CITRIC ACID
Tier 1 Monograph · SSOT 15 FieldsRaw .md (GEO) ↗
합성 (Synthetic)

CITRIC ACID

식약처 한글 표준명: 시트릭애씨드
pH조절제킬레이트제향료완충제
[식약처 공정서 기원 및 정의] 이 원료는 다음의 구조를 갖는 유기산이다.
[EU CosIng Official Definition] Citric Acid is the organic acid that conforms to the formula:
결론 선행 Executive Regulatory & Safety Fact BoxAEO / GEO CITATION ANCHOR

화장품에서 시트릭애씨드 (CITRIC ACID)의 글로벌 배합 한도와 핵심 효능·처방 기준은 무엇인가요?

시트릭애씨드(표준 INCI: CITRIC ACID, CAS 번호: 77-92-9)은 화장품 처방에서 주로 pH조절제, 킬레이트제, 향료 목적으로 배합되는 핵심 원료입니다. 한국 식약처(미규제) 및 유럽 CosIng(제한) 등 6대 권역 법정 기준 하에 관리되며, 통상 0.01–6%(적정 pH 4–8) 범위에서 안정적으로 처방됩니다.

7대 갈래 국가별·용도별 공식 전성분 라벨 표기명 매트릭스

각국 1차 법원 고시 정본 · 기계번역·임의 음차 0건
7-Track Official Statutory Label Names for CITRIC ACID
국가·규제 트랙공식 고시 전성분 표기명원클릭 복사
① 한국 (MFDS 화장품 한글 표준명)시트릭애씨드
② 한국 구명칭 (개정 전 이력 · 301 리다이렉트)——
③ 유럽 (EU CosIng EC 1223/2009)CITRIC ACID
④ 미국 일반화장품 (US PCPC / MoCRA INCI)CITRIC ACID
⑤ 미국 OTC (FDA Active Ingredient Monograph)— (비-OTC 일반 화장품 원료)—
⑥ 중국 (NMPA IECIC 표준 중문명)柠檬酸
⑦ 일본 일반화장품 / 의약부외품 (JCIA / MHLW)クエン酸 · [QD: クエン酸]

Layer 1 — 글로벌 6대 권역 법정 배합 한도 및 규제 상태

Layer 1 Statutory Regulatory Limits Across 6 Regions for CITRIC ACID
권역규제 상태배합 한도제한 조건 및 1차 법원 출처
한국 (MFDS)미규제GMP공식 화장품 원료 목록 등재 (GMP 기준 사용)
유럽 (CosIng)제한GMP공식 화장품 원료 목록 등재 (GMP 기준 사용)
미국 (FDA/CIR)미규제GMP공식 화장품 원료 목록 등재 (GMP 기준 사용)
중국 (NMPA)등재·허용GMPIECIC Entry #4849
일본 (MHLW)미규제GMP공식 화장품 원료 목록 등재 (GMP 기준 사용)
아세안 (ACD)미규제GMP공식 화장품 원료 목록 등재 (GMP 기준 사용)

Layer 2 — 독성·안전성 평가 한도 (US CIR · EU SCCS MoS≥100 · CN IECIC 최고역사사용량)

「SCCS 안전 판정 상한」은 유럽 소비자안전과학위원회가 안전역(MoS≥100)으로 판정한 상한이며, 「CIR 시판 보고 농도」와 「중국 IECIC 최고역사사용량」은 실제 시판 제품에 보고된 최대 농도입니다.

Layer 2 Toxicological & Historical Safe Use Concentrations for CITRIC ACID
안전성 평가 기준적용 부위·유형안전 농도 범위판정 결과 및 문헌 번호
중국 IECIC 최고역사사용량leave_on≤ 5%안전 판정(MoS≥100)NMPA IECIC (2025) Entry 04812 (2025)
중국 IECIC 최고역사사용량rinse_off≤ 5%안전 판정(MoS≥100)NMPA IECIC (2025) Entry 04812 (2025)
⚠️ 참조용 안내 (법적 면책 공지): 이 사전의 성분명·규제 한도·배합 가이드는 연구·개발 참조용으로만 제공됩니다. 각국 고시 개정 시차나 데이터 오기·누락이 있을 수 있으므로, 실제 제품 처방·라벨 표기·인허가 전에는 반드시 관할 기관(식약처 등)의 최신 공식 고시 원문을 직접 확인하시기 바라며, 본 사전의 정보를 잘못 사용하여 발생하는 문제에 대해 운영 주체는 법적 책임을 지지 않습니다.
제형군별 사분위수(Min–Q1–Median–Q3–Max) 분포 그래프

Layer 3 제형군별 통상 배합 농도(%) 레인지 & Layer 1 법정 한도 대조

세정 폼·샴푸 (린스오프)n=10
Min 0.01% · Q1 0.125% · Median 0.3% · Q3 0.5325% · Max 6%
O/W · W/O 에멀전·크림n=11
Min 0.04% · Q1 0.1% · Median 0.3% · Q3 0.55% · Max 1.5%
세정 폼·샴푸 (린스오프) — 린스오프 세정·클렌징 처방 계면 안정화 및 사용감 개선
공식 검증 원천: Global Starter Formulation Library Statistical Distribution (n=10, GRANT 7 · SEPPIC 3) (cir_safety) · GRANT 7 · SEPPIC 3
권장 중앙값: 0.3%

Layer 3 — 제형군별 통상 배합 농도(n≥5 사분위수) & 물리화학·상용성 가이드

Layer 3 Formulation Concentration Quartiles by Product Category for CITRIC ACID
제형군 분류Min – Q1 – Median – Q3 – Max (%)처방 역할 및 기전Source ID
제형군 C — 세정 워시오프 · 폼 · 샴푸 · 바디워시0.01% · 0.125% · 0.3% · 0.5325% · 6%린스오프 세정·클렌징 처방 계면 안정화 및 사용감 개선Global Starter Formulation Library Statistical Distribution (n=10, GRANT 7 · SEPPIC 3)
제형군 B — 유화 로션 · 에멀전 · 크림 (O/W · W/O)0.04% · 0.1% · 0.3% · 0.55% · 1.5%유화 로션·크림 제형 구조 형성 및 피부 컨디셔닝Global Starter Formulation Library Statistical Distribution (n=11, GRANT 7 · SEPPIC 3 · EVONIK 1)
피부 투과 과학 시각화 (Bos & Meinardi 500 Dalton Rule)MW: Macro/Complex · LogP: N/A

각질층 장벽 투과 깊이 & 바이오 스피큘 경피전달(DDS) 시뮬레이션

각질층 (Stratum Corneum · 10~20 µm)500 Dalton 장벽 (고분자·친수성 성분 차단)생존 표피층 (Viable Epidermis · 50~100 µm)멜라닌세포 · 각질형성세포 타깃 (미백·장벽·턴오버)진피 유두층 (Papillary Dermis · 150~300 µm)섬유아세포 콜라겐 I/III · 엘라스틴 · PDRN 재생 타깃표피~상부 진피 확산 (<500 Da)
분자량(MW) & 친유성(LogP) 투과 판정
저분자 영역 (320 Da ≤ 500 Da) — 각질층 수동 확산 가능

단독 도포 시 각질층 세포간 지질(Brick & Mortar) 경로를 통해 확산됩니다. 500 Dalton 이상 친수성 분자는 각질층 표면에 주로 머물러 보습·보호막 역할을 수행합니다.

예상 도달 깊이
40–90 µm
권장 전달 시스템
Polyol Enhancer / Serum
계면화학 · pH · 열역학 공정 시각화

pH 안정성 스펙트럼(0~14) · 가열 한계 게이지 · HLB 콜로이드 상거동

Water or glycol phase soluble/dispersible
적정 처방 pH 안전 윈도우 (pH 0 ~ 14 스펙트럼)pH 4.0 – 8.0
0245.5791114

권장 구간 밖(pH < 4 또는 pH > 8)에서는 가수분해·점도 저하·이온 탈리 위험이 증가합니다.

공정 가열 한계 온도 (Max Process Temp)≤ 50°C
25°C45°C60°C75°C85°C100°C

최대 50°C 가열 공정에서 열적 안정성이 유지됩니다.

계면활성·유화 HLB 스펙트럼 (0 ~ 20) & 미셀/액정 배열 시뮬레이터
O/W 수중유형 미셀 에멀전 (수분 크림·로션)
HLB 11.5
W/O (3–6)Lamellar (8–10.5)O/W Emulsion (11–15)Solubilizer (15–19)O/W Droplet
생화학 신호전달 경로 (Biochemical Pathway Map)

세포·분자 타깃 작용 기전 플로우 다이어그램

1. 각질층·표피 작용→ 촉진·활성 (Activation)
각질층 세포간 지질 & 수분 결합 네트워크
→
경피수분손실(TEWL) 억제 및 피부결 개선
2. 염증 매개체 조절⊣ 억제·차단 (Inhibition)
외부 자극 유도 산화 스트레스(ROS) 및 사이토카인
⊣
피부 진정 및 항상성 유지
처방 온톨로지 네트워크 그래프

권장 시너지(🟢 실선) & 배합 금기·주의(🔴 점선) 인터랙티브 관계도

+ GLYCERIN+ CAPRYLIC/CAPRIC TR…+ TOCOPHEROL✕ 처방 내 극단적 pH 조건 및 고농도…CITRIC ACID
노드 인터랙션 가이드

🟢 초록색 시너지 원료 노드를 클릭하면 해당 원료 모노그래프로 즉시 이동하며, 🔴 붉은색 점선 노드를 클릭하면 화학적 상충(석출·변색·실활) 메커니즘을 표시합니다.

대표 상용명 참고 (상표법 제90조 제1항 제2호 설명적 표기)
CITRIC ACID

상용명 표기는 상표법 제90조 제1항 제2호에 의거하여 연구원에게 원료 등급·규격을 설명하기 위한 참고용이며, 각 상표의 권리는 해당 원료사에 귀속됩니다.

학술·독성·제형 종합 요약 (Tier 1~3 탄력 요약)

Tier 1 Synthesis

이 원료에 매칭된 PubMed 동료심사 논문 초록과 공인 독성 보고서만으로 작성된 학술 요약입니다.

■ [1. 화학적 정체성 및 규격 (Chemical Identity & Standard Nomenclature)] - 표준명: 시트릭애씨드 | INCI: CITRIC ACID | CAS No.: 77-92-9 | EC No.: 201-069-1 - 기원 및 분류: SYNTHETIC | 주요 기능: pH조절제, 킬레이트제, 향료, 완충제 - 물리화학 스펙: 분자식 복합 조성이거나 단일 화학식 미지정 | 분자량 고분자/복합물(Polymer/Complex) | 친수/친유 밸런스 특화 | 이온성: non-ionic | CosIng/MFDS 등재 - 7대 권역 공식 라벨 표기: KR [시트릭애씨드] · EU [CITRIC ACID] · US [CITRIC ACID] · CN [柠檬酸] · JP [クエン酸] · JP의약부외품 [クエン酸] ■ [2. 피부과학적 작용 기전 및 제형 내 역할 (Mechanism of Action & Function)] - 이 원료는 다음의 구조를 갖는 유기산이다. 물리화학적 분류상 기원(synthetic)에 기반하여 피부 장벽 및 제형 매트릭스 내에서 고유한 기능(pH조절제, 킬레이트제, 향료, 완충제)을 수행하며, 계면 안정화·보습·피부 컨디셔닝 또는 유효성분 전달에 기여합니다. ■ [3. 글로벌 6대 권역 법정 규제 및 안전성 한도 (Layer 1 & Layer 2 Regulatory Matrix)] - 6개국 요약: KR: NONE | EU: RESTRICTED | US: NONE | CN: ALLOWED | JP: NONE | ASEAN: NONE (중국 IECIC(2025) 등재번호 4849 (柠檬酸)) - [EU / COMPOSITION / limited] (최대 0.2%): - 공인 안전성·역사적 사용 농도(Layer 2): CN_IECIC_2025 (cn_iecic_max, leave_on): 최대 5.0% / CN_IECIC_2025 (cn_iecic_max, rinse_off): 최대 5.0% ■ [4. 제형군별 통상 배합 가이드 (Layer 3-A Formulation Dosage Guide)] - [cleanser_rinse] 권장 범위: 0.01 ~ 6.0% (중앙값 0.3%, 근거: Global Starter Formulation Library Statistical Distribution (n=10, GRANT 7 · SEPPIC 3)) — 린스오프 세정·클렌징 처방 계면 안정화 및 사용감 개선 - [emulsion_cream] 권장 범위: 0.04 ~ 1.5% (중앙값 0.3%, 근거: Global Starter Formulation Library Statistical Distribution (n=11, GRANT 7 · SEPPIC 3 · EVONIK 1)) — 유화 로션·크림 제형 구조 형성 및 피부 컨디셔닝 ■ [5. 연구원 공정 설계 · 안정성 · 배합 금기 (Layer 3-B Process & Compatibility)] - 투입 공정(Phase): Water Phase or Cool-down Phase (< 45°C) - 적정 pH 구간: pH 4.0 ~ 8.0 | 공정 내열 온도: 최대 50°C | 전해질(염) 내성: MEDIUM - 배합 주의/금기: 처방 내 극단적 pH 조건 및 고농도 전해질과의 상용성 사전 확인 권장 - 시너지 추천 원료: GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL | 참고 상용 원료명: CITRIC ACID ■ [6. 학술 논문 및 공인 문헌 근거 (Peer-Reviewed Literature & Compendia)] - PMID 42177924 (2026, Int J Pharm): Repurposing copper diethyldithiocarbamate (CuET) in a polymeric nanofibrous patch for topical therapy of psoriasis - PMID 42134806 (2026, Radiat Res): Efficacy of Widely Available and Easy-to-Prepare Solutions for Skin Decontamination with Manganese-56 Chloride and Oxide - PMID 42068825 (2026, J Chromatogr A): Electrospun polyvinyl alcohol/LDH nanofibers modified with sodium dodecyl sulfate as a coating for fiber-in-tube solid-p

근거 동료심사 학술 논문 (미국 NIH PubMed) (12)

Repurposing copper diethyldithiocarbamate (CuET) in a polymeric nanofibrous patch for topical therapy of psoriasis [PMID: 42177924 · 2026]
Guo X, Meng Q, Liu W, Rui H, Ruan X, Guan T, Dai A, Liu Y, Su J, Duan C · Int J Pharm (2026)

The management of psoriasis remains challenging due to the limitations of current therapies. This study explores the repurposing of copper diethyldithiocarbamate (CuET)-a metabolite of the anti-alcoholism drug disulfiram-as a novel topical agent for psoriasis. To this end, we developed an advanced delivery platform by fabricating a CuET-loaded nanofiber patch via electrospinning of a polyvinylpyrrolidone/polyethylene glycol/citric acid (PVP/PEG/CA) blend. This rationally designed matrix provided optimal mechanical strength, moisture-activated adhesion, and precise local drug delivery performance, thereby addressing the application challenges associated with xerotic psoriatic skin. In an imiquimod-induced psoriasis mouse model, the nanofiber patch exhibited efficacy comparable to the that of clinical standard clobetasol propionate ointment, significantly alleviating clinical scores and epidermal hyperplasia. Mechanistically, the patch mediated a multimodal therapeutic action: it potently suppressed pathological angiogenesis (reducing CD31&#xa0;+&#xa0;vessel density by 73.97%) and macrophage infiltration. Crucially, it normalized the dysregulated immune microenvironment by concurrently inhibiting key pro-inflammatory cytokines (IL-17A, IL-22, and IL-1&#x3b2;) and restoring the anti-inflammatory cytokine IL-10 to physiological levels, indicating a reset of the Th17/Treg balance. Comprehensive safety evaluation revealed no systemic toxicity. This work not only validates psoriasis as a new therapeutic indication for CuET but also presents a pioneering combined strategy of drug repurposing and material engineering, offering a safe and effective topical therapy that targets the core immune-vascular pathology of the disease.

Efficacy of Widely Available and Easy-to-Prepare Solutions for Skin Decontamination with Manganese-56 Chloride and Oxide as Models for Water-Soluble and Insoluble Radioactive Compounds [PMID: 42134806 · 2026]
Hermann C, Port M, Eder S, R&#xf6;sch R, Stetter F, Gro&#xdf;-Alltag F, Lamkowski A · Radiat Res (2026)

Radio nuclear attack scenarios are potential threats that state actors must deal with more than ever in the context of preparedness and response since the Cold War. Radioactive contamination can occur in many scenarios, which means that, in addition to increased skin- and whole-body doses from external radiation exposure, there is also a risk of incorporation and contamination carryover. In many contexts, only theoretical considerations have been made about which substances would be suitable for removing various radioactive compounds. The goal of this work is to systematically investigate the efficacy of various skin decontamination agents in aqueous solutions, e.g., soap, urea peroxide, EDTA, citric acid, and hydrochloric acid. As a model radionuclide we utilized Manganese-56 in two chemical forms: 1. 56MnCl2 and 2. 56MnO2. The contamination was deposited on the surface of ex vivo pig skin during a 15 min contamination protocol. Pre- and post-decontamination measurements were performed by using a lead-shielded gamma spectrometer in a standardized geometry. The counts in 180 s were analyzed after decay and background correction. The decontamination process involved a standardized 30-second spray followed by a single wipe on the pig skin performed by the same decontaminating experimenter. While the tested decontamination agents were approximately equally efficient in removing water-insoluble radioactive contamination (56MnO2), decontamination from water-soluble 56MnCl2 showed a dependency on the decontamination agents. We found that low-concentration aqueous acid solutions (e.g., 3% citric acid) showed a considerably enhanced efficiency compared to a 1% soap solution.

Electrospun polyvinyl alcohol/LDH nanofibers modified with sodium dodecyl sulfate as a coating for fiber-in-tube solid-phase microextraction of trace fungicides in cosmetic samples [PMID: 42068825 · 2026]
Pourhosseini S, Yamini Y, Nasrollahi SS · J Chromatogr A (2026)

A sensitive analytical protocol was developed to quantify trace levels of three azole fungicides-ketoconazole (KZ), miconazole (MZ), and clotrimazole (CZ)-in cosmetic matrices. This method integrates fiber-in-tube solid-phase microextraction (FIT-SPME) with high-performance liquid chromatography and ultraviolet detection (HPLC-UV). The extraction medium utilized magnesium-aluminum layered double hydroxides (LDHs) intercalated with sodium dodecyl sulfate (SDS), prepared via urea hydrolysis. To fabricate the sorbent, this modified LDH was embedded within a polyvinyl alcohol (PVA) solution-chosen for its green chemistry attributes-and electrospun onto stainless steel substrates. To prevent dissolution in aqueous samples, the coating was thermally cross-linked using citric acid, ensuring robust mechanical stability. The device consisted of these coated fibers housed within a steel capillary, through which samples were circulated for equilibrium adsorption, followed by solvent desorption. A rigorous optimization process was conducted to determine ideal conditions for pH, ionic strength, flow rates, and timing variables. Performance metrics revealed low limits of detection (0.3-0.6 &#xb5;g L -1 ) and high precision, with inter-day relative standard deviations (RSDs) not exceeding 6.2%. The technique displayed a broad linear dynamic range (up to 750.0 &#xb5;g L -1 ) and satisfactory determination coefficients (R 2 &gt; 0.9913). Finally, the analysis of real samples, including shampoos, creams, and lotions, yielded relative recoveries ranging from 82% to 115%, confirming the method's reliability for complex formulations.

Salt-stable ZnO nanoparticles stabilized by citric-acid-crosslinked Canna edulis ker. starch [PMID: 42031252 · 2026]
Gabriel AA, Yonezawa T · Int J Biol Macromol (2026)

This study examines how citric acid crosslinking density in Canna edulis ker. starch (CEkS) governs electrosteric stabilization of ZnO nanoparticles under saline stress. Citric acid-modified CEkS polymers spanning degrees of substitution (DS&#xa0;=&#xa0;0.26-0.67) were synthesized and used to cap ZnO nanoparticles via aqueous co-precipitation. FTIR and XRD confirmed ester formation and ZnO crystallinity, while thermal analysis indicated enhanced thermal resilience of the crosslinked polymer-ZnO system. Colloidal stability was quantified by hydrodynamic diameter (DLS), zeta potential, and UV-Vis turbidity during storage across 0-200&#xa0;mM NaCl. An intermediate-crosslinked formulation (CA35%) provided the most robust salt tolerance: at 200&#xa0;mM NaCl, CA35% reached 1271&#xa0;&#xb1;&#xa0;5&#xa0;nm after 7&#xa0;days, whereas the non-modified CEkS control grew to 2633&#xa0;&#xb1;&#xa0;18&#xa0;nm. In salt-free dispersions, CA35% remained 301&#xa0;&#xb1;&#xa0;2&#xa0;nm at 7&#xa0;days, while the control reached 2896&#xa0;&#xb1;&#xa0;6&#xa0;nm. Higher-crosslinked samples formed stiffer shells that were less tolerant to ionic compression, accelerating aggregation despite more negative surface charge. Overall, the results establish a practical crosslinking-stability design rule for polysaccharide-capped ZnO nanocolloids in ionic media and provide a foundation for subsequent, application-specific validation where safety or regulatory testing is required.

Laboratory evaluation of the erosive potential of fluoride-free mouthwashes using a dental erosion simulation model [PMID: 42013426 · 2026]
Valdivia-Tapia AC, Hara AT, Cury JA, Ricomini-Filho AP, Lippert F · Am J Dent (2026)

To investigate the enamel/dentin surface loss caused by acidic fluoride-free mouthwashes using dental erosion simulation model. Enamel and dentin bovine slabs (n=8) were subjected to 5 days of treatment (four 1-minute mouthwash treatments/day). Six fluoride-free mouthwashes (MW1-MW6) with varying pH (3.03-5.12) were tested. Three 0.3% citric acid solutions (pH 3.0-5.0) and deionized water served as controls. Surface loss (SL) was measured using non-contact profilometry; enamel hardness was assessed via Knoop microhardness. Data was analyzed using one-way ANOVA. For both substrates, the model was able to differentiate between the controls. Differences between PC5 and NC (0.06&#xb1; 0.11/-0.13&#xb1; 0.28) were only directional for enamel. SL ranged considerably between MW1-MW6; however, all were less erosive than PC3 in both substrates. In enamel, MW1 (0.20&#xb1; 0.12), MW3 (-0.26&#xb1; 0.29), and MW6 (0.01&#xb1; 0.12) were not different from NC. MW4 (-0.48&#xb1; 0.29) was not different from PC4 and PC5, whereas MW5 (-1.19&#xb1; 0.59) was more erosive than PC5. The SL data for dentin were mostly comparable to enamel. In dentin, MW1 (-0.34&#xb1; 0.30), MW3 (-0.68&#xb1; 0.45), and MW6 (-0.79&#xb1; 0.17) were also not different from NC. Some fluoride-free mouthwashes may cause dental hard tissue erosion, particularly in dentin. Erosive potential appeared to be influenced more by composition than by pH alone. The findings highlight that mouthwash formulations significantly influence enamel and dentin surface loss, with acidity and specific ingredients playing a key role. Clinicians should exercise caution when recommending fluoride-free mouthwashes, especially to patients at risk of erosive tooth wear.

Carbon dot based topical application for therapy of phosphorus oxide-induced cutaneous burns [PMID: 41981086 · 2026]
Kuznietsova H, Byelinska I, Zaderko A, Pylypova O, Rybalchenko N, Lysenko V, Dziubenko N · Sci Rep (2026)

White phosphorus and phosphorus oxide (PO) burns combine thermal and chemical injury, causing deep, progressive necrosis and systemic inflammation. This study evaluated whether carbon dots (CDs) synthesized from citric acid and urea can improve healing of PO-induced skin burns and reduce systemic damage. CDs showed broad antimicrobial activity, most pronounced against Staphylococcus aureus. Application of CD-containing dressings stabilized burn progression, preventing early aggravation and excessive edema, while promoting transient epithelial proliferation during the first week post-burn. Systemically, CDs normalized elevated white blood cell and neutrophil counts, restored lymphocyte balance, and suppressed IL-6 elevation, confirming anti-inflammatory action. They also mitigated erythrocyte loss and anemia development without affecting liver or kidney function. Overall, CD topical application demonstrated antimicrobial, anti-inflammatory, and cytoprotective effects, moderating PO burn progression and supporting balanced wound repair. These findings identify carbon dots as a promising multifunctional platform for the treatment of complex chemical-thermal skin injuries.

Impact of soy- and milk-based yogurts on enamel preservation: erosion and abrasion under simulated conditions [PMID: 42240712 · 2026]
Kim RR, Braga AS, Floret GP, Roehler A, Schultheiss J, Magalh&#xe3;es AC, Esteves-Oliveira M · Clin Oral Investig (2026)

This study evaluated the effect of soy-based and milk-based yogurts against enamel erosive-abrasive surface loss. Ninety-eight bovine enamel specimens were randomly allocated to seven experimental groups (n&#x2009;=&#x2009;14). Over seven days, specimens underwent six daily erosive cycles (0.05&#xa0;M citric acid, pH 2.3, 2&#xa0;min), interspersed with remineralizing solution (pH 6.5). Post-acid preventive measures consisted of immersion in milk-based yogurt (pH 4.4), soy-based yogurt (pH 4.7), or tap water for 3&#xa0;min twice daily. Under erosion-abrasion conditions, specimens underwent simulated toothbrushing using stannous ions-containing fluoride toothpaste. Fluoride-free toothpaste served as abrasion control. Enamel surface loss was measured after 7 days using three-dimensional laser scanning microscopy. Calcium and phosphorus contents were quantified by optical emission spectrometry. Abrasion with a stannous ions-containing fluoride toothpaste combined with soy-based yogurt resulted in significantly lower enamel surface loss (7.9&#xb1;3.3&#xa0;&#x3bc;m) compared with the fluoride toothpaste only (12.2&#x2009;&#xb1;&#x2009;2.7&#xa0;&#x3bc;m; p&lt;0.05). Under erosion-only conditions, no significant differences were detected among preventive measures. Milk-based yogurt presented significantly higher calcium and phosphorus contents (Ca: 1434.1&#xb1;190.3&#xa0;&#xb5;g/g; P: 1033.8&#xb1;128.1&#xa0;&#xb5;g/g) than soy-based yogurt (Ca: 168.4&#xb1;15.5&#xa0;&#xb5;g/g; P: 623.2&#xb1;47.7&#xa0;&#xb5;g/g). The tested soy yogurt may offer adjunctive protection in patients exposed to erosive and abrasive challenges. The tested soy yogurt significantly enhances anti-erosive efficacy of fluoride-stannous formulations, providing clinicians with an evidence-based dietary intervention to optimize preventive strategies against erosive enamel loss.

Review on the Potential Anti-aging Effects of Gastrodia elata [PMID: 42059229 · 2026]
Wang R, Xin C, Liu W, Cheng Z, Zhu H, Han J · Curr Pharm Des (2026)

Gastrodia elata Blume (G. elata) is a valuable traditional Chinese medicine (TCM) that has been widely used in China. We systematically reviewed tonic and life-extending records in ancient medical literature, as well as the life-prolonging and senescence-delaying effects identified in modern pharmacological research, to provide a theoretical basis for the clinical application and product development of G. elata in tonification and anti-aging. Scientific databases, including CNKI (Chinese literature) and PubMed, were searched to gather relevant literature on the anti-aging effects of G. elata. The targets of the main chemical components of G. elata were predicted and collected through a database, and the intersection of compound targets and disease targets was identified. Protein-protein interaction network analysis, Gene Ontology enrichment, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed to explore the potential mechanisms underlying the anti-aging effects of G. elata. The record of G. elata demonstrates a definitive life-extending effect. Modern pharmacological studies have confirmed that it prolongs the lifespan of short-lived animals and slows the aging processes of the brain, skin, bone, and skeletal muscle in animals. Network pharmacology analysis identified 15 common targets shared between candidate target genes of G. elata and anti-aging target genes. TP53, ESR1, EP300, SIRT1, STAT3, CCND1, HDAC2, MDM2, PPARG, TNF, and HSP90AA1 were identified as core genes in the protein-protein interaction (PPI) network analysis. KEGG enrichment analysis indicated that the anti-aging mechanisms of G. elata may be associated with chemical receptor activation, insulin resistance, the citric acid cycle, the PPAR signaling pathway, the glucagon signaling pathway, and the thyroid hormone signaling pathway. This article summarizes previous studies and modern research on the anti-aging effects of G. elata, suggesting that it holds significant potential for clinical applications in anti-aging.

Development of poly(vinyl alcohol)/poly(N-vinyl caprolactam)-based hydrogel-forming microneedle for transdermal delivery of captopril: fabrication, characterization and in vivo antihypertensive activity test [PMID: 42020839 · 2026]
Fatriyah S, Nizardo NM, Saputri FC, Jung H, Lee A, Mulyadi CA, Willie YBA, Marwah M, Ramadon D · Drug Deliv Transl Res (2026)

Transdermal drug delivery systems, including microneedles (MNs), offer advantages over oral administration by bypassing gastrointestinal degradation and first-pass metabolism, while also reducing injection-associated pain. Hydrogel-forming microneedles (HFMNs) represent a promising advancement in this field as an alternative strategy. This study aimed to develop an HFMN using poly(vinyl alcohol)/poly(N-vinyl caprolactam) (PVA/PNVCL) with citric acid (CA) as crosslinking agent for transdermal delivery of captopril as a drug model. The HFMNs fabrication was optimised by varying crosslinking time, PNVCL concentration, and CA concentration. Evaluations were conducted on physical properties, mechanical strength, insertion ability, in vitro permeation, and drug content. In vivo skin irritation and antihypertensive efficacy tests were also assessed. A crosslinking time of 45&#xa0;min, CA concentration of 1.0%, and 10% PNVCL significantly increased the insertion ability, swelling index, permeability and mechanical strength of the HFMNs. Among six formulations, F3 (PVA 15%; PNVCL 10%; CA 1%) demonstrated the most promising performance, achieving in vitro permeation of 66.68&#x2009;&#xb1;&#x2009;2.78%. In vivo studies showed that oral and transdermal delivery of captopril effectively lowered blood pressure in hypertension-induced rats, with transdermal delivery showing superior efficacy, which warrants further clinical investigation. In addition, in the in vivo skin irritation test, it was observed that HFMNs did not cause irritation. The optimised hydrogel-forming microneedles demonstrated enhanced mechanical strength, permeability, and drug delivery performance. Captopril transdermal delivery using PVA/PNVCL-based HFMNs showed superior antihypertensive efficacy compared to oral administration, with no skin irritation observed, supporting its potential for safe and effective clinical application.

Lemon Juice Activity Against Caprine Alphaherpesvirus-1: An In Vitro Study [PMID: 41892456 · 2026]
Pellegrini F, Lanave G, Catella C, Bachmann V, Dibari M, Tempesta M, Martella V, Decaro N, Trombetta CM, Camero M · Antibiotics (Basel) (2026)

Caprine herpesvirus 1 (CpHV-1) is responsible for significant economic losses in goat farming. The CpHV-1 genital infection in goats has been used as a homologous animal model for the study of human herpes simplex virus type 2 (HSV-2). This study aimed to investigate the in vitro virucidal and antiviral effect of lemon juice (LJ) and its main component, citric acid (CA), against CpHV-1 on Madin-Darby Bovine Kidney (MDBK) cells. Cytotoxicity was assessed using an XTT assay, while viral titers were determined by the Reed-Muench method and viral DNA was quantified via qPCR. Pure LJ (pH 2.3) and its corresponding CA solution demonstrated potent and rapid virucidal activity, reducing the viral titer by over 5.0 log10 TCID 50 /50 &#xb5;L within 1 min. When applied after viral entry, a non-cytotoxic dilution of LJ (pH 4.32) significantly inhibited viral replication, causing a 2.5 log10 TCID 50 /50 &#xb5;L reduction in viral titer and a corresponding decrease in viral DNA. The antiviral effects were minimal at a near-neutral pH of 6.67, probably interacting with envelope structures. These results suggest that LJ could be a potential low-cost topical agent or disinfectant for controlling CpHV-1 in goat populations and offer a basis for translational research on human herpesviruses.

Targeting of Staphyloxanthin and α-Hemolysin by Natural Compound L-Malic Acid Suppresses Staphylococcus aureus Virulence [PMID: 42216777 · 2026]
Shen L, Wang B, Yang J, et al. · FASEB J (2026)

The escalating prevalence of antibiotic resistance in Staphylococcus aureus has underscored the urgent necessity for groundbreaking anti-infective therapies that target novel pathways. Metabolic intermediates, such as those in the TCA cycle, have been known to be linked to bacterial virulence. L-Malic acid (L-MA), a natural TCA cycle intermediate, is known for its antimicrobial and antioxidant properties; however, its effect on the virulence of Staphylococcus aureus has yet to be explored. It was found that L-malic acid not only inhibited bacterial growth but also markedly reduced the production of crucial virulence factors, including staphyloxanthin and &#x3b1;-hemolysin. The suppression of pigment synthesis was primarily due to the competitive antagonism of CrtO, a key oxidoreductase responsible for carotenoid biosynthesis in Staphylococcus aureus, coupled with enhanced flux through the TCA cycle that redirected acetyl-CoA pools away from the mevalonate pathway. Moreover, hemolytic activity was decreased by lowering the expression of &#x3b1;-hemolysin. In&#xa0;vivo studies using mouse infection models further demonstrated that L-malic acid effectively mitigated the pathogenicity of Staphylococcus aureus, significantly reducing the formation of skin and liver abscesses. These findings position L-malic acid as a promising agent targeting Staphylococcus aureus infections, highlighting the need for further research into its therapeutic potential.

Riboflavin Deficiency [PMID: 29262062 · 2026]
Sina RE, Daley SF · PubMed Journal (2026)

자주 묻는 질문 (AEO 스니펫 최적화 FAQ)

Q1. 시트릭애씨드 (CITRIC ACID)의 국가별 공식 전성분 표기명은 어떻게 다른가요?
한국 식약처 표준명은 '시트릭애씨드', 미국 PCPC 및 유럽 CosIng INCI 표기는 'CITRIC ACID', 중국 NMPA IECIC 표준명은 '柠檬酸', 일본 화장품 표시명칭은 'クエン酸'입니다.
Q2. 시트릭애씨드의 글로벌 6대 권역 법정 배합 한도(Layer 1)는 무엇인가요?
한국(KR: none), 유럽(EU: restricted), 미국(US: none), 중국(CN: allowed), 일본(JP: none), 아세안(ASEAN: none) 고시 기준을 준수하여 처방해야 합니다.
Q3. 제형 설계 시 시트릭애씨드의 통상 배합 농도(Layer 3)와 적정 pH는 얼마인가요?
대표 제형군(cleanser_rinse) 기준 통상 0.01~6%(권장 중앙값 0.3%) 범위로 투입하며, 적정 pH는 4~8입니다.
Q4. 시트릭애씨드 배합 시 주의해야 할 상용성 금기(Incompatibilities)와 시너지 성분은 무엇인가요?
주요 권장 시너지 조합은 GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL이며, 배합 주의사항은 처방 내 극단적 pH 조건 및 고농도 전해질과의 상용성 사전 확인 권장입니다.